Use of Arginase in Combination with 5FU and Other Compounds for Treatment of Human Malignancies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Nov 27, 2008
app pub date -
May 21, 2007
filing date -
May 21, 2007
priority date (Note) -
Abandoned
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Abstract
The present invention provides a method for treating cancer in a human patient by reducing the physiological arginine levels to below 10 .mu.M in combination with administering an anti-neoplastic compound. The present invention also provides a pharmaceutical composition comprising an arginine reducing compound, such as pegylated human arginase I, and an anti-neoplastic compound, such as 5-fluorouracil, for the treatment of malignancies in a human patient.
First Claim
all claims..Other Claims data not available
Family
- No Family data available.
- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
BIO-CANCER TREATMENT INTERNATIONAL LIMITED | HONG KONG |
International Classification(s)

- 2007 Application Filing Year
- A61K Class
- 9805 Applications Filed
- 5595 Patents Issued To-Date
- 57.07 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Cheng, Ning Man | Hong Kong, CN | 11 | 26 |
# of filed Patents : 11 Total Citations : 26 | |||
Leung, Yun Chung | Hong Kong, CN | 19 | 33 |
# of filed Patents : 19 Total Citations : 33 | |||
Lo, Wai Hung | Hong Kong, CN | 7 | 15 |
# of filed Patents : 7 Total Citations : 15 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 2 Citation Count
- A61K Class
- 11.28 % this patent is cited more than
- 17 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
- No Legal Status data available.

Matter Detail

Renewals Detail
